• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events

Insight on Research

Cryo-ET reveals new molecular insights into tau pathology in Alzheimer’s disease

Published on 26 November, 2024

Benjamin Ryskeldi-Falcon’s group in the LMB’s Neurobiology Division have used cryo-ET to discover that tau filaments are tethered to the membranes of extracellular vesicles in Alzheimer’s disease. These findings introduce membrane tethering of amyloid filaments as a potential target to interfere with their accumulation in disease.

Why do infectious and autoimmune diseases result in joint pain or inflammation?

Published on 25 November, 2024

Tetsuo Hasegawa and Menna Clatworthy, in the University of Cambridge’s Molecular Immunity Unit house at the LMB, studied a synovial knee joint, finding porous capillaries which allow access by circulating immune stimuli, which is in turn policed by a blood-joint barrier of macrophages and nociceptor neurons.

Whole brain connectome of fruit fly is most complex brain ever mapped

Published on 2 October, 2024

An international collaboration, including Greg Jefferis’ group in the LMB’s Neurobiology Division, have published the connectome of the Drosophila fly – the most complex brain to be mapped in its entirety, including 140,000 neurons and over 15 million connections.

Using ultrasound to determine pregnancy in mice

Published on 20 September, 2024

Introduction of ultrasound machines has allowed LMB animal technicians to accurately detect pregnancy in mice as early as 5.5 days, which ultimately reduces the number of mice needed for research.

New potential therapy for neurodegeneration removes tau aggregates and improves motor function

Published on 13 September, 2024

Leo James’ group, in the LMB’s PNAC Division, have worked with Will McEwan’s group at the UK Dementia Research Institute to design two new therapeutics which harnesses cellular machinery to remove tau aggregates, improving motor skills in mice affected by neurodegenerative disease.

Unprecedented heteromeric amyloid structure in neurodegenerative disease

Published on 11 September, 2024

Surprising advance to our understanding of neurodegenerative diseases, as Diana Arseni and Benjamin Ryskeldi-Falcon in the LMB’s Neurobiology Division find that frontotemporal lobar degeneration Type C filaments include both annexin A11 and TDP-43 in a unique heteromeric structure.

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 62
  • Go to Next Page »

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed.